Cite
ULBP2 is a biomarker related to prognosis and immunity in colon cancer.
MLA
Yang, Xiaoping, et al. “ULBP2 Is a Biomarker Related to Prognosis and Immunity in Colon Cancer.” Molecular & Cellular Biochemistry, vol. 478, no. 10, Oct. 2023, pp. 2207–19. EBSCOhost, https://doi.org/10.1007/s11010-022-04647-2.
APA
Yang, X., Su, X., Wang, Z., Yu, Y., Wu, Z., & Zhang, D. (2023). ULBP2 is a biomarker related to prognosis and immunity in colon cancer. Molecular & Cellular Biochemistry, 478(10), 2207–2219. https://doi.org/10.1007/s11010-022-04647-2
Chicago
Yang, Xiaoping, Xiaolu Su, Zirui Wang, Yi Yu, Zhiping Wu, and Dekui Zhang. 2023. “ULBP2 Is a Biomarker Related to Prognosis and Immunity in Colon Cancer.” Molecular & Cellular Biochemistry 478 (10): 2207–19. doi:10.1007/s11010-022-04647-2.